Publication | Open Access
Serum endostatin predicts tumor vascularity in hepatocellular carcinoma
55
Citations
30
References
2002
Year
The measurement of serum endostatin can predict tumor vascularity and may serve as a promising tool in the antiangiogenic therapy for patients with HCC.
| Year | Citations | |
|---|---|---|
Page 1
Page 1